New trial aims to free organ recipients from lifelong pills
NCT ID NCT06997471
First seen May 13, 2026 · Last updated Jun 09, 2026 · Updated 3 times
Summary
This early-stage study tests whether giving a special mix of immune cells after an organ transplant can help the body accept the new organ without needing lifelong anti-rejection medication. Ten children and adults receiving kidney, lung, or intestinal transplants will get the cell infusion after a stable recovery period. The main goal is to see if the approach is safe and can reduce the risk of rejection and infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID ORGAN TRANSPLANT COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
La Paz University Hospital
RECRUITINGMadrid, Madrid, 28046, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.